CN102816865A - H1n1、prrsv、csfv四重检测试剂盒 - Google Patents
H1n1、prrsv、csfv四重检测试剂盒 Download PDFInfo
- Publication number
- CN102816865A CN102816865A CN2011103369315A CN201110336931A CN102816865A CN 102816865 A CN102816865 A CN 102816865A CN 2011103369315 A CN2011103369315 A CN 2011103369315A CN 201110336931 A CN201110336931 A CN 201110336931A CN 102816865 A CN102816865 A CN 102816865A
- Authority
- CN
- China
- Prior art keywords
- gene
- solution
- csfv
- h1n1virus
- porcine reproductive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 33
- LXWYCLOUQZZDBD-LIYNQYRNSA-N csfv Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O)C1=CC=C(O)C=C1 LXWYCLOUQZZDBD-LIYNQYRNSA-N 0.000 title claims description 77
- 241001135989 Porcine reproductive and respiratory syndrome virus Species 0.000 title abstract description 9
- 239000000523 sample Substances 0.000 claims abstract description 113
- 238000006243 chemical reaction Methods 0.000 claims abstract description 39
- 238000003908 quality control method Methods 0.000 claims abstract description 33
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 20
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 15
- 102000004190 Enzymes Human genes 0.000 claims abstract description 10
- 108090000790 Enzymes Proteins 0.000 claims abstract description 10
- 238000003757 reverse transcription PCR Methods 0.000 claims abstract description 10
- 108090000623 proteins and genes Proteins 0.000 claims description 192
- 241000700605 Viruses Species 0.000 claims description 122
- 208000011580 syndromic disease Diseases 0.000 claims description 83
- 230000001850 reproductive effect Effects 0.000 claims description 82
- 238000000034 method Methods 0.000 claims description 57
- 239000011159 matrix material Substances 0.000 claims description 52
- 101150115318 GP5 gene Proteins 0.000 claims description 48
- 239000000047 product Substances 0.000 claims description 43
- 238000012360 testing method Methods 0.000 claims description 33
- 230000002441 reversible effect Effects 0.000 claims description 20
- 239000012634 fragment Substances 0.000 claims description 18
- 208000015181 infectious disease Diseases 0.000 claims description 18
- 201000010099 disease Diseases 0.000 claims description 17
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 17
- 210000002966 serum Anatomy 0.000 claims description 17
- 239000007850 fluorescent dye Substances 0.000 claims description 16
- 238000013467 fragmentation Methods 0.000 claims description 16
- 238000006062 fragmentation reaction Methods 0.000 claims description 16
- 239000003153 chemical reaction reagent Substances 0.000 claims description 15
- 239000013612 plasmid Substances 0.000 claims description 14
- 230000002458 infectious effect Effects 0.000 claims description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- 238000012408 PCR amplification Methods 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 238000002156 mixing Methods 0.000 claims description 10
- 239000006228 supernatant Substances 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000002299 complementary DNA Substances 0.000 claims description 9
- 239000002773 nucleotide Substances 0.000 claims description 9
- 125000003729 nucleotide group Chemical group 0.000 claims description 9
- 230000001575 pathological effect Effects 0.000 claims description 9
- 238000004321 preservation Methods 0.000 claims description 9
- -1 CSFV nucleic acid Chemical class 0.000 claims description 8
- 230000004087 circulation Effects 0.000 claims description 8
- 239000002512 suppressor factor Substances 0.000 claims description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 5
- 238000004458 analytical method Methods 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- UDGUGZTYGWUUSG-UHFFFAOYSA-N 4-[4-[[2,5-dimethoxy-4-[(4-nitrophenyl)diazenyl]phenyl]diazenyl]-n-methylanilino]butanoic acid Chemical compound COC=1C=C(N=NC=2C=CC(=CC=2)N(C)CCCC(O)=O)C(OC)=CC=1N=NC1=CC=C([N+]([O-])=O)C=C1 UDGUGZTYGWUUSG-UHFFFAOYSA-N 0.000 claims description 4
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 claims description 4
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 claims description 4
- 102000006382 Ribonucleases Human genes 0.000 claims description 4
- 108010083644 Ribonucleases Proteins 0.000 claims description 4
- 230000008506 pathogenesis Effects 0.000 claims description 4
- 230000004044 response Effects 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 3
- 150000003254 radicals Chemical class 0.000 claims description 3
- 238000012986 modification Methods 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 238000001921 nucleic acid quantification Methods 0.000 claims description 2
- 238000005516 engineering process Methods 0.000 abstract description 18
- 230000035945 sensitivity Effects 0.000 abstract description 10
- 241000712461 unidentified influenza virus Species 0.000 abstract description 8
- 239000000126 substance Substances 0.000 abstract description 6
- 230000001360 synchronised effect Effects 0.000 abstract description 6
- 239000000284 extract Substances 0.000 abstract description 5
- 241000710777 Classical swine fever virus Species 0.000 abstract description 4
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 4
- 238000003753 real-time PCR Methods 0.000 abstract description 3
- 102100034343 Integrase Human genes 0.000 abstract description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 abstract description 2
- 206010069767 H1N1 influenza Diseases 0.000 abstract 2
- 201000010740 swine influenza Diseases 0.000 abstract 2
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 abstract 1
- 239000003161 ribonuclease inhibitor Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 46
- 108020004414 DNA Proteins 0.000 description 36
- 239000013615 primer Substances 0.000 description 32
- 230000003321 amplification Effects 0.000 description 18
- 238000003199 nucleic acid amplification method Methods 0.000 description 18
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 17
- 241000282898 Sus scrofa Species 0.000 description 11
- 239000000427 antigen Substances 0.000 description 11
- 102000036639 antigens Human genes 0.000 description 11
- 108091007433 antigens Proteins 0.000 description 11
- 238000003745 diagnosis Methods 0.000 description 11
- 210000001519 tissue Anatomy 0.000 description 11
- 238000009396 hybridization Methods 0.000 description 10
- 210000003800 pharynx Anatomy 0.000 description 10
- 230000003612 virological effect Effects 0.000 description 10
- 229920000742 Cotton Polymers 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 239000012528 membrane Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 239000002987 primer (paints) Substances 0.000 description 7
- 206010011732 Cyst Diseases 0.000 description 6
- 238000000018 DNA microarray Methods 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 208000031513 cyst Diseases 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000002245 particle Substances 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 230000000890 antigenic effect Effects 0.000 description 5
- 206010022000 influenza Diseases 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- 108091028043 Nucleic acid sequence Proteins 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000002146 bilateral effect Effects 0.000 description 4
- 229960001701 chloroform Drugs 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000001493 electron microscopy Methods 0.000 description 4
- 230000005284 excitation Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 4
- 230000003472 neutralizing effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 238000005057 refrigeration Methods 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 230000001900 immune effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 238000011999 immunoperoxidase monolayer assay Methods 0.000 description 3
- 238000007857 nested PCR Methods 0.000 description 3
- 238000006386 neutralization reaction Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- 238000011895 specific detection Methods 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- 101710154606 Hemagglutinin Proteins 0.000 description 2
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 2
- 101710093908 Outer capsid protein VP4 Proteins 0.000 description 2
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 2
- 241000228143 Penicillium Species 0.000 description 2
- 239000004793 Polystyrene Substances 0.000 description 2
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 description 2
- 101710176177 Protein A56 Proteins 0.000 description 2
- 108020005202 Viral DNA Proteins 0.000 description 2
- 230000002785 anti-thrombosis Effects 0.000 description 2
- 229960004676 antithrombotic agent Drugs 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 208000032625 disorder of ear Diseases 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000000185 hemagglutinin Substances 0.000 description 2
- 230000003118 histopathologic effect Effects 0.000 description 2
- 238000007901 in situ hybridization Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 238000003771 laboratory diagnosis Methods 0.000 description 2
- 210000001161 mammalian embryo Anatomy 0.000 description 2
- 210000002050 maxilla Anatomy 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 239000002751 oligonucleotide probe Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 241000710929 Alphavirus Species 0.000 description 1
- 108091093088 Amplicon Proteins 0.000 description 1
- 241001292006 Arteriviridae Species 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 241000710781 Flaviviridae Species 0.000 description 1
- 241000710198 Foot-and-mouth disease virus Species 0.000 description 1
- 241000606807 Glaesserella parasuis Species 0.000 description 1
- 101710170453 Glycoprotein 55 Proteins 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 101150072436 H1 gene Proteins 0.000 description 1
- 208000028782 Hereditary disease Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241001500351 Influenzavirus A Species 0.000 description 1
- 241001500350 Influenzavirus B Species 0.000 description 1
- 101710203526 Integrase Proteins 0.000 description 1
- 238000007397 LAMP assay Methods 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 208000024556 Mendelian disease Diseases 0.000 description 1
- 241000711513 Mononegavirales Species 0.000 description 1
- 102000005348 Neuraminidase Human genes 0.000 description 1
- 108010006232 Neuraminidase Proteins 0.000 description 1
- 101800000512 Non-structural protein 1 Proteins 0.000 description 1
- 101800001019 Non-structural protein 4B Proteins 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 208000001300 Perinatal Death Diseases 0.000 description 1
- 241000710778 Pestivirus Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241001673669 Porcine circovirus 2 Species 0.000 description 1
- 101710194807 Protective antigen Proteins 0.000 description 1
- 102000017975 Protein C Human genes 0.000 description 1
- 101800001554 RNA-directed RNA polymerase Proteins 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 238000010240 RT-PCR analysis Methods 0.000 description 1
- 101100209986 Rattus norvegicus Slc18a1 gene Proteins 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 101710137500 T7 RNA polymerase Proteins 0.000 description 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 1
- 102100040247 Tumor necrosis factor Human genes 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 108091036078 conserved sequence Proteins 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000105 evaporative light scattering detection Methods 0.000 description 1
- 238000012817 gel-diffusion technique Methods 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 238000002649 immunization Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000000951 immunodiffusion Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000001524 infective effect Effects 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000007403 mPCR Methods 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229960000856 protein c Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000011155 quantitative monitoring Methods 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000013207 serial dilution Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 125000005630 sialyl group Chemical group 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 238000004879 turbidimetry Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 210000002845 virion Anatomy 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
序号 | Ct |
1.1 | 2.21785 |
1.2 | 2.06356 |
1.3 | 2.03591 |
1.4 | 2.12024 |
2.1 | 30.3778 |
2.2 | 30.4813 |
2.3 | 30.1306 |
2.4 | 30.3707 |
3.1 | Undet. |
3.2 | Undet. |
3.3 | Undet. |
3.4 | Undet. |
序号 | Ct |
1.1 | Undet. |
1.2 | 21.2626 |
1.3 | 5.1246 |
1.4 | 23.8802 |
2.1 | 16.3118 |
2.2 | 23.1865 |
2.3 | 5.08192 |
2.4 | 22.1521 |
3.1 | Undet. |
3.2 | Undet. |
3.3 | Undet. |
3.4 | Undet. |
工作标准品 | Ct | C(初始浓度) |
1.0e+009 | 3.347 | 1.0e+009 |
1.0e+008 | 6.294 | 1.0e+008 |
1.0e+007 | 9.671 | 1.0e+007 |
1.0e+006 | 13.365 | 1.0e+006 |
slope | -3.343074 | - |
intercept | 33.242611 | - |
R2 | 0.997493 | - |
工作标准品 | Ct | C(初始浓度) |
1.0e+009 | 3.7541 | 1.0e+009 |
1.0e+008 | 6.76272 | 1.0e+008 |
1.0e+007 | 10.0734 | 1.0e+007 |
1.0e+006 | 13.8102 | 1.0e+006 |
slope | -3.347902 | - |
intercept | 33.709377 | - |
R2 | 0.997627 | - |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110336931.5A CN102816865B (zh) | 2011-10-31 | 2011-10-31 | H1n1、prrsv、csfv四重检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201110336931.5A CN102816865B (zh) | 2011-10-31 | 2011-10-31 | H1n1、prrsv、csfv四重检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102816865A true CN102816865A (zh) | 2012-12-12 |
CN102816865B CN102816865B (zh) | 2014-04-02 |
Family
ID=47301308
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110336931.5A Expired - Fee Related CN102816865B (zh) | 2011-10-31 | 2011-10-31 | H1n1、prrsv、csfv四重检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102816865B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104531897A (zh) * | 2014-12-05 | 2015-04-22 | 广东省农业科学院动物卫生研究所 | 一种csfv、prrsv-u和prrsv-m的三色荧光pcr检测方法及其试剂盒 |
CN105936944A (zh) * | 2016-04-22 | 2016-09-14 | 浙江省检验检疫科学技术研究院 | Csfv、prrsv和siv h1亚型的三重荧光rt-pcr检测试剂盒及引物、探针 |
CN107447053A (zh) * | 2017-09-19 | 2017-12-08 | 中国动物疫病预防控制中心 | 猪繁殖与呼吸综合征病毒通用型微滴数字pcr绝对定量检测试剂盒 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101614737A (zh) * | 2009-06-02 | 2009-12-30 | 青岛康地恩药业有限公司 | 一种胶体金试纸条及其制备方法和应用 |
CN101736094A (zh) * | 2010-03-02 | 2010-06-16 | 福建省农业科学院畜牧兽医研究所 | 变异型猪繁殖与呼吸综合征病毒TaqMan荧光定量RT-PCR检测试剂盒及应用 |
CN101886139A (zh) * | 2009-05-11 | 2010-11-17 | 北京索奥生物技术有限公司 | 一种新型甲型流感病毒h1n1亚型双色荧光pcr检测方法及其试剂盒 |
CN102108418A (zh) * | 2009-12-25 | 2011-06-29 | 中国科学院广州生物医药与健康研究院 | 甲型h1n1流感病毒的环介导等温扩增检测方法及试剂盒 |
-
2011
- 2011-10-31 CN CN201110336931.5A patent/CN102816865B/zh not_active Expired - Fee Related
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101886139A (zh) * | 2009-05-11 | 2010-11-17 | 北京索奥生物技术有限公司 | 一种新型甲型流感病毒h1n1亚型双色荧光pcr检测方法及其试剂盒 |
CN101614737A (zh) * | 2009-06-02 | 2009-12-30 | 青岛康地恩药业有限公司 | 一种胶体金试纸条及其制备方法和应用 |
CN102108418A (zh) * | 2009-12-25 | 2011-06-29 | 中国科学院广州生物医药与健康研究院 | 甲型h1n1流感病毒的环介导等温扩增检测方法及试剂盒 |
CN101736094A (zh) * | 2010-03-02 | 2010-06-16 | 福建省农业科学院畜牧兽医研究所 | 变异型猪繁殖与呼吸综合征病毒TaqMan荧光定量RT-PCR检测试剂盒及应用 |
Non-Patent Citations (2)
Title |
---|
刘辉等: "猪瘟病毒、猪繁殖与呼吸障碍综合征病毒和乙型脑炎病毒多重RT-PCR检测方法的建立", 《华中农业大学学报》 * |
陈钟鸣等: "应用实时荧光定量PCR方法检测猪繁殖与呼吸综合征和猪瘟病毒", 《中国畜牧兽医学会家畜传染病学分会第七届全国会员代表大会暨第十三次学术研讨会论文集(上册)》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104531897A (zh) * | 2014-12-05 | 2015-04-22 | 广东省农业科学院动物卫生研究所 | 一种csfv、prrsv-u和prrsv-m的三色荧光pcr检测方法及其试剂盒 |
CN105936944A (zh) * | 2016-04-22 | 2016-09-14 | 浙江省检验检疫科学技术研究院 | Csfv、prrsv和siv h1亚型的三重荧光rt-pcr检测试剂盒及引物、探针 |
CN105936944B (zh) * | 2016-04-22 | 2019-12-20 | 浙江省检验检疫科学技术研究院 | Csfv、prrsv和siv h1亚型的三重荧光rt-pcr检测试剂盒及引物、探针 |
CN107447053A (zh) * | 2017-09-19 | 2017-12-08 | 中国动物疫病预防控制中心 | 猪繁殖与呼吸综合征病毒通用型微滴数字pcr绝对定量检测试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN102816865B (zh) | 2014-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107513584B (zh) | 一种检测肠道病毒的五重荧光定量试剂盒 | |
WO2006000140A1 (fr) | Amorces, sequences sondes et procedes utiles dans plusieurs dosages rt-pcr fluorescents en temps reel des sous-types h5, h7 et h9 du virus de la grippe aviaire | |
CN104232798B (zh) | 鸭甲型肝炎病毒检测与基因a型和c型鉴别的多重荧光定量pcr方法及试剂盒 | |
CN103509877B (zh) | 一种用于检测prv的荧光定量pcr试剂盒及其应用 | |
CN102337351B (zh) | 一种流感病毒分型检测试剂盒 | |
CN110699489B (zh) | 非洲猪瘟病毒cd2v基因的实时荧光pcr检测引物探针组、试剂盒及方法 | |
CN108676920A (zh) | 一种快速检测小鼠诺如病毒引物、试剂盒及其rt-rpa方法 | |
CN103131798A (zh) | 一种诺如病毒实时荧光rt-pcr检测试剂盒及其应用 | |
CN1840703A (zh) | 动物水泡性疾病多重rt-pcr鉴别检测试剂及制备方法和应用 | |
CN105543414A (zh) | 一种呼吸道合胞病毒a/b亚型多重荧光定量pcr检测引物组和探针组及其试剂盒和制备方法 | |
CN105002298B (zh) | 一种鲤春病毒血症病毒的荧光定量pcr检测方法 | |
CN101328506B (zh) | 一种特异检测猪瘟病毒野毒感染的荧光定量pcr快速诊断试剂盒及其应用方法 | |
CN113846191B (zh) | 用于检测新型冠状病毒的引物、探针及其应用 | |
CN105886663A (zh) | 一种锁核酸增敏的猪伪狂犬病毒野毒株荧光定量pcr的检测试剂盒 | |
CN102816865B (zh) | H1n1、prrsv、csfv四重检测试剂盒 | |
CN105154584B (zh) | 一种快速区分prrsv经典毒株和变异毒株的hrm非标记探针方法及其引物和探针 | |
CN108330211A (zh) | A组轮状病毒/星状病毒/肠道腺病毒核酸多重荧光pcr检测试剂盒及其用途 | |
CN101724712B (zh) | 动物虫媒病多重rt-pcr鉴别检测试剂及制备方法和应用 | |
CN108624713A (zh) | 一种猪伪狂犬病疫苗毒与野毒鉴别检测的方法及试剂盒 | |
CN103409554B (zh) | 一种快速检测麻疹病毒/风疹病毒的核酸检测试剂盒 | |
CN102676691B (zh) | H1n1、prrsv、o-fmdv四重检测试剂盒 | |
CN108411014A (zh) | 鉴别a型和b型牛多杀性巴氏杆菌的双重实时荧光定量pcr的引物和探针以及检测方法 | |
CN102676690B (zh) | 猪瘟病毒核酸定量检测试剂盒、检测方法、引物及其探针 | |
CN102337352B (zh) | 一种pcr微阵列检测多种流感病毒的试剂盒 | |
CN110305986A (zh) | Sva、o型fmdv和a型fmdv的一步法三重实时荧光定量pcr检测引物和探针 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: WUHAN WANDERUI BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: WUHAN UNIVERSITY Effective date: 20140728 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 430072 WUHAN, HUBEI PROVINCE TO: 430074 WUHAN, HUBEI PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20140728 Address after: 430074 Hubei Development Zone, East Lake high tech Avenue, No. 666 Wuhan national biological industry base project B, C, D District R & D building B1 building, Patentee after: WONDERARRAY BIOTECH CO., LTD. Address before: 430072 Hubei Province, Wuhan city Wuchang District of Wuhan University Luojiashan Patentee before: Wuhan University |
|
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20121212 Assignee: Wuhan Optics Valley new drug incubation public service platform Co., Ltd. Assignor: WONDERARRAY BIOTECH CO., LTD. Contract record no.: 2015420000057 Denomination of invention: H1N1, PRRSV and CSFV quadruple detection kit Granted publication date: 20140402 License type: Exclusive License Record date: 20150427 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160705 Address after: 430074 Hubei Development Zone, East Lake high tech Avenue, No. 666 Wuhan national biological industry base project B, C, D District R & D building B1 building, Patentee after: Wuhan Optics Valley new drug incubation public service platform Co., Ltd. Address before: 430074 Hubei Development Zone, East Lake high tech Avenue, No. 666 Wuhan national biological industry base project B, C, D District R & D building B1 building, Patentee before: WONDERARRAY BIOTECH CO., LTD. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: H1N1, PRRSV and CSFV quadruple detection kit Effective date of registration: 20181226 Granted publication date: 20140402 Pledgee: Wuhan rural commercial bank Limited by Share Ltd Optics Valley branch Pledgor: Wuhan Optics Valley new drug incubation public service platform Co., Ltd. Registration number: 2018420000078 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140402 Termination date: 20201031 |